There was a small but statistically significant negative relation between baseline PASI (estimate − 0.015, p = 0.0129) and DLQI (estimate − 0.0117, p = 0.0499) and the probability of updosing was of marginal significance.
← all excerpts
Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry.
1
—
—